ClinicalTrials.Veeva

Menu
H

Hospital El Cruce | Area de Investigacion

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

ION-682884
Eplontersen
Lampalizumab
Milvexian
BMS-986165
Deucravacitinib

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

3 of 14 total trials

A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome (LIBREXIA-ACS)

The purpose of this study is to evaluate that milvexian is superior to placebo, in addition to standard-of-care, in reducing the risk of major advers...

Enrolling
Acute Coronary Syndrome
Drug: Milvexian
Other: Placebo

The purpose of this study is to evaluate the safety and tolerability of extended dosing with Eplontersen in participants with hereditary transthyreti...

Enrolling
Hereditary Transthyretin-Mediated Amyloid Polyneuropathy
Drug: Eplontersen
Locations recently updated

The purpose of this study is to evaluate the effectiveness and safety of deucravacitinib compared with placebo in an active moderate to severe System...

Enrolling
Systemic Lupus Erythematosus
Drug: Deucravacitinib
Other: Placebo

Trial sponsors

H
Ionis Pharmaceuticals logo
Bristol-Myers Squibb (BMS) logo
Fresenius Kabi logo
Janssen (J&J Innovative Medicine) logo
Roche logo
University of Washington logo
A
C

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems